Robert M. Lorence
12Patents
7h-index
13Co-inventors
63Inventor score
Filing activity: Jun 16, 1994 → Jun 28, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8105578B2 | Treatment of neoplasms with viruses | Chemistry; Metallurgy | 31 | Active |
| US7056689B1 | Methods of treating and detecting cancer using viruses | Chemistry; Metallurgy | 17 | Expired |
| US8043612B2 | Infection and treatment of neoplasms with vesicular stomatitis virus | Chemistry; Metallurgy | 13 | Active |
| US7192580B2 | Purging of cells using viruses | Chemistry; Metallurgy | 12 | Expired |
| US7470426B1 | Treatment of neoplasms with viruses | Chemistry; Metallurgy | 11 | Expired |
| US7736640B2 | Methods of treating and detecting cancer using viruses | Chemistry; Metallurgy | 7 | Active |
| US7780962B2 | Treatment of neoplasms with RNA viruses | Chemistry; Metallurgy | 7 | Expired |
| US8012480B2 | Detection of proteins from circulating neoplastic cells | Human Necessities | 6 | Active |
| US8828391B2 | Method for EGFR directed combination treatment of non-small cell lung cancer | Human Necessities | 5 | Active |
| US7767200B2 | Cancer treatment using viruses, fluoropyrimidines and camptothecins | Chemistry; Metallurgy | 1 | Active |
| US8557531B2 | Detection of circulating endothelial cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US9844574B2 | Cancer treatment using viruses and camptothecins | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.